Product

AU409

Aliases

AU409 capsules

1 clinical trial

1 indication

Indication

Hepatocellular Carcinoma

Clinical trial

A Phase I, Single-arm, Open-label, Dose-escalation, Safety and Pharmacokinetic Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

Status: Recruiting, Estimated PCD: 2026-02-28